Andreas Kaubisch, MD, discusses the phase III REACH and REACH-2 trials in advanced hepatocellular carcinoma.
Andreas Kaubisch, MD
Advertisement
Articles by Andreas Kaubisch, MD
Andreas Kaubisch, MD, discusses available treatment options for hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Kaubisch on Treatment Options for HCCPublished: November 2nd 2019 | Updated:
Dr. Kaubisch on the REACH Trials in HCCPublished: November 21st 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5